V ascular endothelial cells in culture 1 and in vivo 2 internalize and degrade oxidized LDL (ox-LDL) through a putative receptor-mediated pathway that does not seem to involve the classic macrophage scavenger receptor. The endothelial receptor for ox-LDL (LOX-1) is a membrane protein that belongs structurally to the C-type selectin family and is expressed in vivo in vascular endothelium and in vascular-rich organs. 3 Because endothelial uptake of ox-LDL is important in the genesis of atherosclerosis, understanding of the role and regulation of LOX-1 may be of immense clinical significance.
Recent studies show that cytokine tumor necrosis factor (TNF)-␣ 4 and fluid shear stress 5 markedly upregulate LOX-1 gene expression in endothelial cells. Another study 6 has shown that LOX-1 expression is dramatically increased in hypertensive rats. A more recent study from our laboratory 7 has demonstrated that angiotensin II upregulates LOX-1 expression as well as the uptake of ox-LDL in human coronary artery endothelial cells (HCAECs).
It is widely appreciated that LDL, especially its oxidatively modified form (ox-LDL), is a critical factor in atherogenesis.
Endothelial dysfunction elicited by ox-LDL has been identified in the course of atherogenesis and its complications. 8 LDL is oxidized in vascular endothelial cells to a highly injurious product that results in characteristic cell dysfunction in large arteries and resistant vessels. Endothelial dysfunction (ie, loss of vasodilation, vasoconstriction, thrombosis, and inflammation) occurs before and throughout the development of atherosclerosis and particularly during plaque rupture.
Ox-LDL appears to induce this cellular dysfunction in a timeand concentration-dependent manner. 9 Recent studies show that apoptosis, which is a common accompaniment of atherosclerosis, is induced by ox-LDL in cultured vascular smooth muscle cells, 10 monocytes/macrophages, 11 and human endothelial cells. 12 The mechanisms of ox-LDL-mediated apoptosis, particularly in endothelial cells, and of its relation with LOX-1 have not been defined.
Nuclear factor (NF)-B, a transcription factor, regulates the transcription of a variety of cellular genes, including injury response and growth control. 13 Activation of NF-B is inhibited by antioxidant compounds, such as N-acetyl-Lcysteine, pyrrolidine dithiocarbamate, 14 and vitamin E. 15 It has thus been proposed that NF-B is primarily an oxidative stress-responsive transcription factor. 14, 15 Previous studies have demonstrated that NF-B is activated in accelerated and in advanced atherosclerosis. 16 Recent studies show that NF-B activation plays a critical role in apoptosis 17, 18 and that ox-LDL induces the activation of NF-B in fibroblasts and in endothelial and smooth muscle cells. 19 Accordingly, we hypothesized that (1) ox-LDL upregulates its own receptor, LOX-1; (2) ox-LDL-mediated apoptosis of cultured HCAECs is associated with the action of LOX-1; and (3) NF-B activation plays an important role in this process. The present study was conducted to examine these hypotheses.
Methods

Cell Culture
The initial batch of HCAECs was purchased from Clonetics Corp. The endothelial cells were pure, on the basis of morphology and staining for factor VIII and acetylated LDL. These cells were 100% negative for ␣-actin smooth muscle expression. Microvascular endothelial growth medium consisted of 500 mL of endothelial cell basal medium, 5 ng of human recombinant epidermal growth factor, 5 mg of hydrocortisone, 25 mg of gentamycin, 25 g of amphotericin B, 6 mg of bovine brain extract, and 25 mL of FBS.
Fifth generation HCAECs 7,12 were incubated with ox-LDL (40 g/mL) for 24 hours to study the expression of LOX-1 as well as NF-B activity. Several groups of HCAECs were incubated with different concentrations of ox-LDL (10 to 100 g/mL) for 24 hours to observe apoptosis. HCAECs were preincubated with antisense to LOX-1 mRNA (antisense LOX-1) or sense LOX-1 (0.5 mol/L) for 48 hours. HCAECs were then incubated with ox-LDL (40 g/mL) to determine the expression of LOX-1. HCAECs incubated with antisense LOX-1 or sense LOX-1 were also used to examine ox-LDLmediated apoptosis and NF-B activation. Parallel groups of HCAECs were incubated with 2 different chemical inhibitors of LOX-1 (250 g/mL polyinosinic acid or 250 g/mL carrageenan) or NF-B inhibitor (25 g/mL caffeic acid phenethyl ester [CAPE]) for 1 hour and then exposed to ox-LDL for 24 hours to observe NF-B activity and apoptosis of HCAECs. The concentration of these inhibitors was based on previous studies. 20, 21 Preparation of Antisense LOX-1
Antisense phosphorothioate oligonucleotides (ODNs) and sense phosphorothioate ODNs (as controls) directed to the 5Ј-coding sequence of the human LOX-1 mRNA were designed and manufactured by Biognostik GmbH. The antisense LOX-1 was synthesized as a 16-mer product (8 bases) targeted at 5Ј-CAG TTA AAT GAG GCC G-3Ј of the LOX-1 sequence. The corresponding control (sense) was 16-mer (8 bases) targeted at 5Ј-ACC TAC GTG ACT ACG T-3Ј. Hereafter, the antisense and sense to LOX-1 mRNA will be referred to as antisense LOX-1 and sense LOX-1, respectively. Logarithmically growing endothelial cells were transfected by adding ODNs into culture medium according to the instructions of the manufacturer. Recent experiments from our laboratory demonstrated that the uptake of antisense LOX-1 was maximal, with 0.5 mol/L after incubation for 48 hours. Hence, the present study describes the use of a 0.5 mol/L concentration of antisense ODNs.
Preparation of Lipoproteins
Native LDL and ox-LDL were prepared as described earlier. 12 In brief, human native LDL was isolated from human blood plasma by discontinuous centrifugation. LDL was oxidized by exposure to CuSO 4 (5 mol/L free Cu 2ϩ concentration) in PBS at 37°C for 24 hours. The thiobarbituric acid-reactive substance content of ox-LDL was 18.2Ϯ0.28 versus 0.56Ϯ0.16 nmol per 100 g protein in the native LDL preparation (PϽ0.01). LDL and ox-LDL were kept in 50 mmol/L Tris-HCl, 0.15 mol/L NaCl, and 2 mmol/L EDTA at pH 7.4 and were used within 10 days of preparation.
RT-PCR for LOX-1 mRNA Expression in HCAECs
Total RNA (1 g) extracted from cultured HCAECs was reversetranscribed with oligo dT (Promega) and M-MLV reverse transcriptase (Promega) at 37°C for 1 hour. Two microliters of the reversetranscribed material was amplified with Taq DNA polymerase (Promega) by using a primer pair specific to human endothelial receptor (sense primer, 5Ј-TTACTCTCCATGGTGGTGCC-3Ј; antisense primer, 5Ј-AGCTTCTTCTGCTTGTTGCC-3Ј). The polymerase chain reaction (PCR) product was 193 bp. For PCR, 35 cycles were used at 94°C for 40 seconds, 55°C for 1 minute, and 72°C for 1 minute. The reverse transcription (RT)-PCR-amplified samples were visualized on 1.5% agarose gels by using ethidium bromide. ␤-Actin was amplified as a reference for quantification of LOX-1 mRNA. The signal intensity of each LOX-1 mRNA band was normalized by that of ␤-actin. The RT-PCR product for LOX-1 was sequenced. The sequence of RT-PCR product for LOX-1 in HCAECs was the same as the previously published sequence for LOX-1. 3, 7 Western Blot Analysis for LOX-1 in HCAECs HCAEC lysates from each experiment (30 g per lane) were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. After incubation in blocking solution (4% nonfat milk, Sigma Chemical Co), membranes were incubated with 1:100 dilution primary antibody (monoclonal antibody to human LOX-1 was a gift of Dr Sawamura, National Cardiovascular Center Research Unit, Osaka, Japan) overnight at 4°C. Membranes were washed and then incubated with secondary antibody (1:2000 dilution, Amersham Life Sciences) for 1 hour, the membranes were detected with the ECL system (Amersham Life Sciences), and relative intensities of protein bands were analyzed by an MSF-300G Scanner (Microtek Laboratory). 7
Determination of Apoptosis
In Situ TUNEL and Propidium Iodide Staining
To detect DNA fragmentation in situ, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) was performed as previously described. 22 Briefly, the cells plated on slides were fixed with 4% methanol-free formaldehyde, pH 7.4, for 25 minutes at 4°C and washed with PBS. The slides were incubated with 0.2% Triton X-100 for 5 minutes on ice to increase cell permeability and were equilibrated with terminal deoxynucleotidyl transferase (TDT) buffer (including 30 mmol/L Tris-HCl, pH 7.2, 140 mmol/L sodium cacodylate, and 1 mmol/L cobalt chloride) for 10 minutes at room temperature. The slides were covered with 0.3 U/L TDT and 0.04 nmol/L fluorescein-12-dUTP (Promega) in TDT buffer for 60 minutes at 37°C. The slides were immersed in 2ϫ SSC buffer for 15 minutes at room temperature and then washed with PBS to remove unincorporated fluorescein-dUTP. The slides were immersed in 1 g/mL of propidium iodide in PBS for 15 minutes at room temperature and washed with deionized water. The slides were viewed under a fluorescence microscope with green fluorescence set at 520 nm and red fluorescence (of propidium iodide) set at Ͼ620 nm. The negative controls were cells without TDT enzyme. The positive controls were samples pretreated with DNase I.
DNA Fragmentation Gel Electrophoresis (DNA Laddering)
HCAECs were removed from culture dishes, washed twice with PBS, and pelleted by centrifugation. Cell pellets were then treated for 10 minutes with lysis buffer (1% NP-40 in 20 mmol/L EDTA and 50 mmol/L Tris-HCl, pH 7.5). After centrifugation for 5 minutes at 1600g, the supernatant was collected, and the extraction was repeated with the same amount of lysis buffer. The supernatants were brought to 1% SDS and treated for 2 hours with RNase A (final concentration 5 g/L) at 56°C, followed by digestion with proteinase K (final concentration 2.5 g/L) for 2 hours at 37°C. After addition of 1/2 vol of 10 mol/L ammonium acetate, the DNA was
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Ox-LDL, LOX-1, and Apoptosisprecipitated with 2.5 vol of absolute ethanol. DNA was recovered by centrifugation at 12 000g for 10 minutes and dissolved in gel loading buffer. DNA was separated by electrophoresis in 1.6% agarose gel with ethidium bromide. 22
Preparation of Nuclear Extracts
Nuclear extracts were prepared as described previously. 22 After centrifugation for 15 minutes at 8000g, the supernatant containing nuclear proteins was transferred to a precooled microcentrifuge tube, and nuclear protein concentration was quantified.
Western Blot for NF-B
Monoclonal antibody to the P65 subunit of NF-B from mouse to mouse hybrid cells was purchased from Boehringer-Mannheim. The antibody recognizes an epitope overlapping the nuclear location signal of the P65 subunit and, therefore, selectively binds the activated form of NF-B. Equal amounts of protein (15 g) from the nuclear extract of each group were separated by 7.5% SDS-PAGE and transferred to nitrocellulose filters (Sigma). The membrane was blocked by incubating the membrane for 1 hour in Tris-saline buffer (pH 7.4) containing 3% nonfat milk (Sigma) and incubating the membrane in the same buffer containing 7.5 g/mL of monoclonal antibody to the P65 subunit of NF-B. Anti-mouse alkaline phosphatase-conjugated antibody was used as a secondary antibody at 1: 3000 dilution. The blot was used for color development on the membrane. Sites of antigen localization turn a dark purple color as a result of alkaline phosphatase activity. Relative intensities of bands of interest were analyzed by use of an MSF-300G Scanner (Microtek Laboratory). 7, 12, 22 
Data Analysis
All data represent the mean of duplicate samples from 6 independently performed experiments. Data are presented as meanϮSD.
Statistical significance was determined in multiple comparisons among independent groups of data in which ANOVA and the F test indicated the presence of significant differences. A value of PϽ0.05 was considered significant.
Results
Regulation of LOX-1 by Ox-LDL
A previous study from our laboratory showed that LOX-1 expression is upregulated by ox-LDL in a concentrationdependent manner, with maximal effect at 40-g/mL. 20 Therefore, a concentration of only 40 g/mL ox-LDL was used in the present study. In keeping with the previous report, incubation of HCAECs with ox-LDL (40 g/mL) for 24 hours increased LOX-1 mRNA (RT-PCR) and protein expression (Western analysis), whereas native LDL had no effect on the regulation of LOX-1. This upregulation of LOX-1 by ox-LDL was blocked by pretreatment of HCAECs with antisense LOX-1, but not with sense LOX-1. Notably, basal LOX-1 mRNA and protein were also suppressed by antisense LOX-1, but not by sense LOX-1 ( Figure 1 ).
Ox-LDL and Apoptosis in HCAECs
Because a small number of cells normally die during culture or are damaged during processing, 1% to 5% (3.8Ϯ1.6%) of control cells stained positive on TUNEL staining. Cultured HCAECs incubated with ox-LDL (10 to 100 g/mL) for 24 hours showed a concentrationdependent increase in the number of apoptotic cells (from 6.8Ϯ3.0% to 48.4Ϯ4.2%). Ox-LDL also caused a timedependent (6-to 24-hour) increase in the number of apoptotic cells (Figure 2 ). The proapoptotic effect of ox-LDL was also confirmed by DNA fragmentation on gel electrophoresis (see below).
LOX-1 Inhibition and Apoptosis in HCAECs
Pretreatment of cells with antisense LOX-1 markedly decreased the number of apoptotic cells in response to ox-LDL (PϽ0.01). In contrast, sense LOX-1 had no effect on the degree of apoptosis. These effects of antisense LOX-1 were confirmed by TUNEL staining (Figure 3 ) and gel electrophoresis ( Figure 4 ). The presence of 2 different chemical inhibitors of LOX-1, polyinosinic acid and carrageenan, in the HCAEC culture medium before the cells were exposed to ox-LDL also reduced the number of apoptotic cells in response to ox-LDL (PϽ0.01). These observations were confirmed by TUNEL staining as well as by DNA laddering (Figure 4 ). inhibited the ox-LDL-mediated activation of NF-B (PϽ0.05, Figure 5 ).
LOX-1 Inhibition and NF-B Activation and Apoptosis in HCAECs
The presence of CAPE, an inhibitor of NF-B, in the cell culture medium before the cells were exposed to ox-LDL markedly reduced the number of apoptotic cells in response to ox-LDL (PϽ0.01), but alone, it had no effect on the magnitude of apoptosis ( Figure 6 ).
Discussion
We have recently identified high-affinity LOX-1 in cultured HCAECs by RT-PCR, Western blot, and radioligand binding. 7, 20 Native LDL does not bind to this receptor. We have also demonstrated that angiotensin II enhances LOX-1 expression, uptake of ox-LDL, and injury to HCAECs. 7 In the present study, we confirm that ox-LDL upregulates the expression of its own endothelial receptor, LOX-1. Additionally, we show that ox-LDL induces apoptosis of HCAECs via action of LOX-1. The critical role of LOX-1 in the genesis of apoptosis became evident in that a highly specific antisense to LOX-1 mRNA as well as 2 different chemical LOX-1 inhibitors attenuated the proapoptotic effect of ox-LDL. Last, these studies indicate that NF-B activation is an important signal transduction mechanism in LOX-1-mediated apoptosis, because the antisense as well as the chemical inhibitors of LOX-1 prevented the ox-LDL-mediated activation of NF-B. The NF-B inhibitor, CAPE, also significantly attenuated the ox-LDL-induced apoptosis of HCAECs.
Regulation of LOX-1
Inflammatory stimuli, such as TNF-␣ and phorbol 12-myristate 13-acetate, increase LOX-1 expression in a timeand dose-dependent fashion in cultured bovine aortic endothelial cells. Upregulation of the expression of LOX-1 by TNF-␣ and phorbol 12-myristate 13-acetate in bovine endothelial cells is associated with an increase in the uptake of ox-LDL. 4 Fluid shear stress, which activates endothelium, also upregulates LOX-1 expression by enhancing intracellular calcium mobilization. 5 In an in vivo study, Nagase et al 6 found that LOX-1 mRNA is markedly upregulated in the aorta and vein of hypertensive rats, which may be the basis of impaired endotheliumdependent vasodilation in these rats. In a recent study, 7 we demonstrated that LOX-1 expression is upregulated by angiotensin II via activation of the Ang II type 1 receptor and that the upregulation of LOX-1 is associated with an increased uptake of ox-LDL by HCAECs and induction of cell injury. In the present study, we confirm that ox-LDL upregulates its own receptor LOX-1 mRNA and protein expression. These observations may be the basis of the increased uptake of ox-LDL and endothelial activation and dysfunction as plasma LDL levels rise.
LOX-1 and Apoptosis
Nishio and Watanabe 10 have suggested that ox-LDL, but not native LDL, induces apoptosis in cultured rabbit vascular smooth muscle cells. Yang et al 11 have also shown that ox-LDL induces apoptosis of human monocytes and macrophages. Recent work from our laboratory 12 has shown that ox-LDL markedly augments hypoxia/reoxygenationmediated apoptosis of cultured HCAECs. Ox-LDL decreases endogenous superoxide dismutase activity and constitutive nitric oxide synthase activity and increases free radical generation beyond that caused by hypoxia/reoxygenation. In the present study, we demonstrate that ox-LDL, per se, induces apoptosis of cultured HCAECs in a concentrationand time-dependent fashion. The importance of LOX-1 expression became obvious in our experiments in which a specific antisense to LOX-1 mRNA decreased ox-LDLmediated apoptosis of HCAECs by 75%. In other experiments, we found that 2 different nonspecific chemical inhibitors of LOX-1, polyinosinic acid and carrageenan, also decreased ox-LDL-mediated apoptosis of HCAECs by 62% and 72%, respectively. Notably these 2 LOX-1 inhibitors prevent [
125 I]ox-LDL binding to LOX-1 by 60% to 90%. 4, 20 Apoptosis in the present study was documented by 2 independent methods, TUNEL stating and gel electrophoresis. The results of the 2 methods were similar and complementary. We have shown previously that apoptosis in HCAECs in response to ox-LDL, as measured by TUNEL staining and DNA laddering, is associated with characteristic changes in markers of apoptosis, such as bcl-2 and Fas proteins. 12 
LOX-1 and NF-B Signal Transduction
The mechanism of ox-LDL-induced apoptosis continues to be discussed. Nishio and Watanabe 10 have shown that oxysterols induce apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Dimmeler et al 23 have shown that ox-LDL induces apoptosis of endothelial cells through activation of CPP32-like proteases. Another study 24 has shown that ox-LDL increases cellular calcium to trigger apoptosis. Recent work 12 from our laboratory has shown that ox-LDL changes the expression of certain genes associated with apoptosis in endothelial cells, such as bcl-2 and Fas. Concurrently, ox-LDL activates protein kinase C and protein tyrosine K, and inhibitors of protein kinase C and protein tyrosine K markedly reduce ox-LDL-mediated apoptosis.
NF-B is an oncogene protein that regulates transcription of a variety of cellular genes, including immune and inflammatory response and growth control. 13 NF-B is present in cytosol as a heterodimer composed of NF-B1 (P50) and Rel (P65) subunits bound to an inhibitor protein, I-B. After activation, NF-B translocates from the cy- tosol to the nucleus of the cell, binds to specific DNA sequences, and initiates transcription. Maziere et al 19 have shown that ox-LDL activates NF-B in fibroblasts and endothelial and smooth muscle cells and causes cell injury. Collins 25 has suggested oxidative activation of endothelial cell transcription factors, especially NF-B, as a mechanism for changing endothelial cell phenotype and for initiating atherosclerotic lesions. Hernan dez-Presa et al 16 have also demonstrated NF-B activation in early atherosclerosis. Other studies have shown a critical role of NF-B activation in myocardial 26 and endothelial cell 17 apoptosis. Some studies have also shown NF-B as a proapoptotic signal in human endothelial cells. 27 It is possible that NF-B activation plays different roles depending on the stimulus and conditions for cell injury. In the present study, we demonstrate that ox-LDL induces NF-B activation. The role of LOX-1 in this process appears to be important, because antisense LOX-1 and chemical LOX-1 inhibitors significantly reduced NF-B activation in cultured HCAECs. Importantly, we found that CAPE, an inhibitor of NF-B, 21 markedly attenuated ox-LDL-induced apoptosis of HCAECs. Natarajan et al 21 demonstrated that CAPE completely blocks the activation of NF-B induced by TNF-␣ but that it has no effect on other transcription factors, such as activator protein-1, Oct-1, and TFIID. Although a few studies show that CAPE also induces apoptosis in fibroblast cells, 28 we did not find evidence for a proapoptotic effect of CAPE. We propose that ox-LDL via LOX-1 triggers a suicide pathway leading to apoptosis in HCAECs and that this pathway is closely linked with the activation of NF-B. It is possible that ox-LDL-induced apoptosis may involve other signal transduction pathways, such as the activation of CPP32-like protease and protein kinase C, because the NF-B inhibitor did not completely block the effect of ox-LDL.
In summary, ox-LDL upregulates the expression of its own receptor in HCAECs. Ox-LDL also induces apoptosis in HCAECs via LOX-1 in concert with upregulation of its receptor, and last, NF-B activation plays an important role as a signal transduction mechanism in this process. The confirmation of these concepts was obtained with the use of a specific antisense to LOX-1 mRNA and 2 different chemical blockers of LOX-1, polyinosinic acid and carrageenan, as well as CAPE, a powerful NF-B inhibitor. These observations may have important implications with regard to the propagation of endothelial cell injury in the presence of ox-LDL.
